by AIP Online Bureau | May 1, 2024 | Eco/Invest/Demography, Health, International News, Risk Management, Technology
This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria “can, in very rare cases, cause Thrombosis Thrombocytopenia Syndrome (TTS).” New Delhi: In light of recent concerns...
by AIP Online Bureau | Jan 26, 2023 | Facts, Health, Pandemic
According to the study, even though homologous and heterologous boosting with Covishield or Covaxin in Covishield or Covaxin primed individuals are immunogenic and safe, boosting with Covishield produced better binding and functional antibodies, irrespective of...
by AIP Online Bureau | Apr 24, 2022 | Eco/Invest/Demography, Health, Indian News, Non-Life, Pandemic
The Indian Council of Medical Research-National Institute of Virology scientists concluded the report saying that the fight against Covid-19 is far from over. Although vaccine boosters or third doses have shown an augmentation in the immune response against the...
by AIP Online Bureau | Mar 20, 2022 | Eco/Invest/Demography, Facts, Health, Pandemic
The decision will lead to accelerated administration of the second dose of Covishield to the remaining six to seven crore individuals amid rising cases in several countries, the source said. The government had on May 13, 2021 extended the gap between the first and...
by AIP Online Bureau | Jan 30, 2022 | Facts, Health, Pandemic
As of now, Covaxin is priced at Rs 1,200 per dose while Covishield costs Rs 780 in private facilities. The prices include Rs 150 service charge New Delhi: The price of Covishield and Covaxin, the Covid vaccines which are expected to soon get regular market approval...
